{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1116.62","meta":{"versionId":"3","lastUpdated":"2023-04-03T13:49:28.000-04:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"CancerLinQ Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2023-04-03"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.62","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113762.1.4.1116.62"}],"version":"20150715","name":"EGFRInhibitor","title":"EGFR inhibitor","status":"active","experimental":false,"date":"2015-07-15T01:00:03-04:00","publisher":"CancerLinQ Steward","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: ),(Data Element Scope: ),(Inclusion Criteria: ),(Exclusion Criteria: )","compose":{"include":[{"system":"http://snomed.info/sct","concept":[{"code":"409402009","display":"Epidermal growth factor receptor inhibitor (substance)"},{"code":"409403004","display":"Epidermal growth factor receptor inhibitor (product)"}]}]},"expansion":{"identifier":"urn:uuid:469871c2-a0fe-45aa-bbd7-2cb0ed54eb36","timestamp":"2023-12-10T21:43:36-05:00","total":2,"contains":[{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20230901","code":"409402009","display":"Substance with epidermal growth factor receptor inhibitor mechanism of action (substance)"},{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20230901","code":"409403004","display":"Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)"}]}}